New York State Common Retirement Fund’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.07M | Buy |
196,293
+7,000
| +4% | +$252K | 0.01% | 912 |
|
|
2025
Q1 | $5.89M | Sell |
189,293
-77,522
| -29% | -$2.41M | 0.01% | 976 |
|
|
2024
Q4 | $6.81M | Sell |
266,815
-13,500
| -5% | -$344K | 0.01% | 965 |
|
|
2024
Q3 | $7.93M | Sell |
280,315
-47,251
| -14% | -$1.34M | 0.01% | 890 |
|
|
2024
Q2 | $8.64M | Buy |
327,566
+16,251
| +5% | +$429K | 0.01% | 880 |
|
|
2024
Q1 | $9.46M | Sell |
311,315
-78,967
| -20% | -$2.4M | 0.01% | 838 |
|
|
2023
Q4 | $11M | Sell |
390,282
-37,697
| -9% | -$1.06M | 0.02% | 780 |
|
|
2023
Q3 | $11.6M | Sell |
427,979
-58,028
| -12% | -$1.57M | 0.02% | 748 |
|
|
2023
Q2 | $14.9M | Sell |
486,007
-16,880
| -3% | -$519K | 0.02% | 700 |
|
|
2023
Q1 | $18.1M | Buy |
502,887
+4,845
| +1% | +$175K | 0.02% | 609 |
|
|
2022
Q4 | $19.7M | Buy |
498,042
+3,807
| +0.8% | +$150K | 0.03% | 569 |
|
|
2022
Q3 | $19.9M | Sell |
494,235
-23,616
| -5% | -$949K | 0.03% | 529 |
|
|
2022
Q2 | $21.8M | Buy |
517,851
+123,850
| +31% | +$5.21M | 0.03% | 507 |
|
|
2022
Q1 | $15.4M | Buy |
394,001
+6,891
| +2% | +$268K | 0.02% | 769 |
|
|
2021
Q4 | $15.4M | Sell |
387,110
-5,571
| -1% | -$222K | 0.02% | 795 |
|
|
2021
Q3 | $14.2M | Buy |
392,681
+19,804
| +5% | +$716K | 0.02% | 841 |
|
|
2021
Q2 | $15.3M | Buy |
372,877
+1,377
| +0.4% | +$56.4K | 0.02% | 793 |
|
|
2021
Q1 | $16.2M | Buy |
371,500
+235,000
| +172% | +$10.3M | 0.02% | 734 |
|
|
2020
Q4 | $6.83M | Buy |
+136,500
| New | +$6.83M | 0.01% | 1132 |
|